Last $221.29 USD
Change Today +5.36 / 2.48%
Volume 1.7M
PCYC On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for pharmacyclics inc (PCYC)

Year over year, Pharmacyclics Inc. has been able to grow revenues from $260.2M USD to $729.7M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to income tax expense from 11.96% to 4.98%. This was a driver that led to a bottom line growth from $67.0M USD to $86.1M USD.
Currency in
Millions of US Dollars
As of:Jun 30
2011
Reclassified
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues8.2164.7260.2729.7
TOTAL REVENUES8.2164.7260.2729.7
Cost of Goods Sold34.560.588.6438.9
GROSS PROFIT-26.2104.2171.5290.9
Selling General & Admin Expenses, Total9.119.673.6168.0
Depreciation & Amortization, Total------0.5
OTHER OPERATING EXPENSES, TOTAL9.119.673.6168.5
OPERATING INCOME-35.484.697.9122.4
Interest and Investment Income0.20.20.30.4
NET INTEREST EXPENSE0.20.20.30.4
Other Non-Operating Income (Expenses)--0.0-0.1-0.4
EBT, EXCLUDING UNUSUAL ITEMS-35.284.898.1122.4
Gain (Loss) on Sale of Investments0.0------
Gain (Loss) on Sale of Assets0.0------
EBT, INCLUDING UNUSUAL ITEMS-35.284.898.1122.4
Income Tax Expense---3.031.136.3
Earnings from Continuing Operations-35.287.867.086.1
NET INCOME-35.287.867.086.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-35.287.867.086.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-35.287.867.086.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCYC:US $221.29 USD +5.36

PCYC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biogen Idec Inc $415.79 USD +6.20
Celgene Corp $120.31 USD -1.22
Genmab A/S kr513.00 DKK +28.00
Gilead Sciences Inc $103.83 USD +0.30
GlaxoSmithKline PLC 1,570 GBp +15.50
View Industry Companies
 

Industry Analysis

PCYC

Industry Average

Valuation PCYC Industry Range
Price/Earnings 100.0x
Price/Sales 22.4x
Price/Book 19.8x
Price/Cash Flow 189.4x
TEV/Sales 21.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMACYCLICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.